E. Koklanaris

发表

Contrast enhanced cardiac CT reveals coronary artery disease in 45% of asymptomatic allo-SCT long-term survivors

C. Hourigan, A. Barrett, S. Shanbhag, 2014, Bone Marrow Transplantation.

Clinical and Biological Predictors of Outcome Following Relapse of Chronic Myeloid Leukemia after Allogeneic Stem Cell Transplantation

K. Rezvani, P. Muranski, K. Keyvanfar, 2014, Bone marrow transplantation.

CMV reactivation is associated with a lower incidence of relapse after allo-SCT for CML

G. Fahle, A. Barrett, R. Childs, 2013, Bone Marrow Transplantation.

Clinical and biological predictors of outcome following relapse of CML post-allo-SCT

P. Muranski, K. Keyvanfar, C. Hourigan, 2015, Bone Marrow Transplantation.

The Level of Minimal Residual Disease in Primitive Progenitor Cells from CML Patients after Allogeneic Stem Cell Transplantation Is Higher Than after Treatment with Tyrosine Kinase Inhibitors.

K. Rezvani, K. Keyvanfar, A. Barrett, 2008 .

Acquired RhD mosaicism identifies fibrotic transformation of thrombopoietin receptor‐mutated essential thrombocythemia

A. Barrett, M. Albitar, H. Klein, 2017, Transfusion.

Premature coronary artery disease following allogeneic stem cell transplantation: an NHLBI Cohort Study

Marcus Y. Chen, J. Barrett, M. Battiwalla, 2018, Bone Marrow Transplantation.

Favorable outcomes in patients surviving 5 or more years after allogeneic hematopoietic stem cell transplantation for hematologic malignancies.

A. Barrett, M. Bevans, S. Mitchell, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Cellular immune profiling after sequential clofarabine and lenalidomide for high risk myelodysplastic syndromes and acute myeloid leukemia

P. Muranski, K. Keyvanfar, A. Barrett, 2017, Leukemia research reports.

Second Hematopoietic Stem Cell Transplantation for Leukemia Relapsing after Myeloablative T Cell Depleted Transplants Does Not Prolong Survival

A. Barrett, N. Hensel, M. Battiwalla, 2013, Bone Marrow Transplantation.

Prolonged chronic graft-versus-host disease is a risk factor for thyroid failure in long-term survivors after matched sibling donor stem cell transplantation for hematologic malignancies.

A. Barrett, B. Savani, S. Goodman, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Male survivors of allogeneic hematopoietic stem cell transplantation have a long term persisting risk of cardiovascular events.

C. Hourigan, A. Barrett, S. Shanbhag, 2014, Experimental hematology.

Lamivudine prophylaxis and hepatitis B vaccination for prevention of hepatitis B virus reverse seroconversion in long-term survivors after allogeneic stem cell transplantation.

R. Childs, B. Savani, A. Shenoy, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Selectively T cell-depleted allografts from HLA-matched sibling donors followed by low-dose posttransplantation immunosuppression to improve transplantation outcome in patients with hematologic malignancies.

A. Barrett, D. Stroncek, R. Childs, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Distinct Biomarker Profiles in Ex Vivo T Cell Depletion Graft Manipulation Strategies: CD34+ Selection versus CD3+/19+ Depletion in Matched Sibling Allogeneic Peripheral Blood Stem Cell Transplantation.

P. Muranski, K. Keyvanfar, A. Barrett, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Risks factors and timing of genital human papillomavirus (HPV) infection in female stem cell transplant survivors: a longitudinal study

A. Barrett, P. Stratton, M. Merideth, 2018, Bone Marrow Transplantation.

Improved reproducibility and quality of GvHD biomarker assay: application of multiplex microfluidic channel system

P. Muranski, A. Barrett, S. Paczesny, 2016, Bone Marrow Transplantation.

Evolution of the donor T-cell repertoire in recipients in the second decade after allogeneic stem cell transplantation.

D. Douek, B. Hill, K. Keyvanfar, 2011, Blood.

Framingham Risk Score Is an Ineffective Screening Strategy for Coronary Heart Disease in Long-Term Allogeneic Hematopoietic Cell Transplant Survivors

A. Barrett, Marcus Y. Chen, R. Childs, 2020, Clinical hematology international.

Very Early Adoptive Transfer of Ex Vivo Generated Multi-Virus Specific T Cells Is a Safe Strategy for Prevention of Viral Infection after Allogeneic T Cell Depleted Stem Cell Transplantation

M. Sabatino, P. Muranski, A. Barrett, 2018, Blood.

Factors influencing the late phase of recovery after bone mineral density loss in allogeneic stem cell transplantation survivors

J. Barrett, M. Battiwalla, B. Savani, 2016, Bone Marrow Transplantation.

Repair of impaired pulmonary function is possible in very-long-term allogeneic stem cell transplantation survivors.

C. Hourigan, A. Barrett, M. Battiwalla, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Bone Marrow Mesenchymal Stromal Cells to Treat Tissue Damage in Allogeneic Stem Cell Transplant Recipients: Correlation of Biological Markers with Clinical Responses

M. Sabatino, Xingmin Feng, J. Melenhorst, 2014, Stem cells.